Continuation of angiotensin converting enzyme inhibitor therapy, in spite of occurrence of angioedema

International Journal of Cardiology

Volumn 201, Issue , 2015, Pages 644-645

  Mahmoudpour, Seyed Hamidreza ^a   Asselbergs, Folkert W ^b   Terreehorst, Ingrid ^c   Souverein, Patrick C ^a   De Boer, Anthonius ^a   Maitland Van Der Zee, Anke H ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Adverse drug reaction; Angiotensin converting enzyme inhibitor; Drug induced angioedema; Prescribing pattern

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PRESCRIPTION DRUG;

ADULT; ANGIONEUROTIC EDEMA; COHORT ANALYSIS; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EXPOSURE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; TREATMENT DURATION; ADVERSE DRUG REACTION; ANGIOEDEMA; CHEMICALLY INDUCED; HYPERTENSION; INCIDENCE; NETHERLANDS; RISK FACTOR; SURVIVAL RATE; TIME FACTOR; TRENDS;

ANGIOEDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; MALE; NETHERLANDS; PRESCRIPTION DRUGS; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 84943529365     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.08.185     Document Type: Article

References (10)

1. K. Croft Prescriptions dispensed in the community England 2003-13 Prescribing and Primary Care 9 July 2014 Health and Social Care Information Centre (110 pp. Available on http://www.hscic.gov.uk)
2. W.H. Inman, N.S. Rawson, L.V. Wilton, G.L. Pearce, and C.J. Speirs Postmarketing surveillance of enalapril. I: results of prescription-event monitoring BMJ 297 1988 826 829
3. M.U. Khan, M.A. Baig, R.A. Javed, and et al. Benazepril induced isolated visceral angioedema: a rare and under diagnosed adverse effect of angiotensin converting enzyme inhibitors Int. J. Cardiol. 118 2007 e68 e69
4. N.J. Brown, M. Snowden, and M.R. Griffin Recurrent angiotensin-converting enzyme inhibitor-associated angioedema JAMA 278 1997 232 233
5. M. Cicardi, L.C. Zingale, L. Bergamaschini, and A. Agostoni Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment Arch. Intern. Med. 164 2004 910 913
6. L. Beltrami, A. Zanichelli, L. Zingale, R. Vacchini, S. Carugo, and M. Cicardi Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema J. Hypertens. 29 2011 2273 2277
7. A. Matcho, P. Ryan, D. Fife, and C. Reich Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model Drug Saf. 37 2014 945 959
8. A.P. Kaplan, and M.W. Greaves Angioedema J. Am. Acad. Dermatol. 53 2005 373 388 (quiz 389-92)
9. N.G. Kounis, A. Mazarakis, C. Bardousis, and N. Patsouras The heart and coronary arteries as primary target in severe allergic reactions: cardiac troponins and the Kounis hypersensitivity-associated acute coronary syndrome Int. J. Cardiol. 198 2015 83 84
10. G. Lippi, R. Buonocore, F. Schirosa, and G. Cervellin Cardiac troponin I is increased in patients admitted to the emergency department with severe allergic reactions. A case-control study Int. J. Cardiol. 194 2015 68 69